Back to Search
KAREN PAWLAK, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1386927341Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
14435-40(WI)
Research & Publications (20)
The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
PMID 18048089·Thromb Res·2008
8-other
Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
PMID 17869326·Thromb Res·2008
8-other
Chronic viral hepatitis and iron affect the plasma levels of LIGHT--a new member of the TNF superfamily in uraemic haemodialyzed patients.
PMID 17827030·Cytokine·2007
4-observational
Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
PMID 17331567·Thromb Res·2007
8-other
Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
PMID 16828495·Thromb Res·2007
4-observational
Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
PMID 17046733·Clin Biochem·2007
8-other
Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
PMID 17391740·Thromb Res·2007
3-trial
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.
PMID 16510149·Atherosclerosis·2007
8-other
Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
PMID 17070067·Cytokine·2006
3-trial
Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
PMID 15964061·Thromb Res·2006
4-observational
Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis.
PMID 16099464·Atherosclerosis·2006
4-observational
Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
PMID 15963971·Clin Biochem·2005
8-other
Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
PMID 15896974·Cytokine·2005
8-other
Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
PMID 15566948·Cytokine·2004
8-other
Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients.
PMID 12818246·Thromb Res·2003
8-other
Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers.
PMID 19117965·Clin Appl Thromb Hemost·2010
3-trial
Soluble angiogenesis markers in gastric tumor patients.
PMID 19419943·Folia Histochem Cytobiol·2009
8-other
Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
PMID 19477487·Thromb Res·2009
8-other
Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
PMID 19572067·Thromb Haemost·2009
8-other
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
PMID 19491664·Blood Coagul Fibrinolysis·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4901 SPRING ST
MOUNT PLEASANT, WI 53406 - Phone
- (262) 886-9643
Quick Facts
- NPI
- 1386927341
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile